Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Report notes fall in European antibiotic sales for animals
Between 2011 and 2015, the sales of antibiotics to treat animals fell by 13.4 per cent.
Picture across Europe still varies 

Sales of antibiotics for use in animals fell in most European countries between 2011 and 2015, according to a new report.

The report, published by the European Medicines Agency (EMA), presents detailed sales data for the year 2015 and yearly changes in antimicrobial consumption dating back to 2010.

It reveals that between 2011 and 2015, the sales of antibiotics to treat animals fell by 13.4 per cent. The result covers 25 out of the 30 participating European countries that provided data.

The report also shows that the situation across Europe still varies. It notes a fall of at least five per cent in 15 countries. However, eight countries recorded an increase of more than five per cent.

The EMA said that, given the substantial decline in the sales of antimicrobials for food-producing species observed for some countries, there is also a potential for a decrease in others.

The report is the seventh of its kind produced by the European Surveillance of Antimicrobial Consumption (ESVAC) project - a partnership between the national authorities throughout the EU that is coordinated by the EMA.

The project was launched in April 2010 following a request from the European Commission. The ESVAC report is issued every year and used by risk assessors and risk managers in the Member States as a reference or antimicrobial policies and for guidance on the responsible use of antimicrobials.

All data in the report are accessible in the ESVAC interactive database.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.